FONR RSI Chart
Last 7 days
1.8%
Last 30 days
-3.3%
Last 90 days
12.0%
Trailing 12 Months
35.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 97.7M | 98.6M | 101.3M | 102.4M |
2022 | 97.5M | 97.6M | 97.1M | 96.8M |
2021 | 86.0M | 89.9M | 92.7M | 96.0M |
2020 | 87.4M | 85.7M | 84.9M | 84.6M |
2019 | 85.7M | 87.2M | 88.2M | 88.5M |
2018 | 81.4M | 81.5M | 82.9M | 83.9M |
2017 | 75.9M | 78.0M | 78.6M | 80.4M |
2016 | 71.5M | 73.4M | 74.5M | 74.5M |
2015 | 69.2M | 69.1M | 68.7M | 70.0M |
2014 | 69.9M | 68.5M | 69.7M | 69.1M |
2013 | 40.1M | 49.1M | 56.5M | 64.5M |
2012 | 0 | 0 | 0 | 38.1M |
2011 | 0 | 0 | 0 | 0 |
2010 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Sep 30, 2022 | damadian timothy raymond | bought | 31,130 | 14.15 | 2,200 | ceo, president & treasurer |
Sep 30, 2022 | bonanni luciano b | bought | 48,144 | 14.16 | 3,400 | exec vp, coo & pfo |
Sep 29, 2022 | damadian timothy raymond | bought | 34,075 | 13.63 | 2,500 | ceo, president & treasurer |
Sep 29, 2022 | bonanni luciano b | bought | 17,966 | 13.82 | 1,300 | exec vp, coo & pfo |
Which funds bought or sold FONR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | unchanged | - | 4,032 | 18,954 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 4.41 | 1,877,720 | 7,635,150 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 249,429 | 249,429 | -% |
Feb 15, 2024 | BARCLAYS PLC | new | - | 124,000 | 124,000 | -% |
Feb 14, 2024 | Royal Bank of Canada | unchanged | - | 62,000 | 291,000 | -% |
Feb 14, 2024 | STATE STREET CORP | added | 6.92 | 111,582 | 423,278 | -% |
Feb 14, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | added | 1.28 | 330,050 | 1,482,360 | 0.03% |
Feb 14, 2024 | RBF Capital, LLC | unchanged | - | 303,921 | 1,429,010 | 0.09% |
Unveiling FONAR Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to FONAR Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 184.1B | 23.9B | 38.82 | 7.71 | ||||
IDXX | 44.8B | 3.7B | 53.05 | 12.25 | ||||
A | 43.2B | 6.7B | 34.96 | 6.42 | ||||
DGX | 14.5B | 9.3B | 16.99 | 1.57 | ||||
CRL | 13.8B | 4.1B | 29.14 | 3.35 | ||||
MEDP | 12.4B | 1.9B | 43.86 | 6.58 | ||||
EXAS | 12.1B | 2.5B | -59.47 | 4.86 | ||||
NTRA | 10.9B | 1.1B | -25.12 | 10.09 | ||||
MID-CAP | ||||||||
NEOG | 3.3B | 918.7M | 284.21 | 3.64 | ||||
GH | 2.2B | 563.9M | -4.56 | 3.88 | ||||
SMALL-CAP | ||||||||
CDNA | 544.7M | 280.3M | -2.86 | 1.94 | ||||
ACRS | 89.4M | 31.2M | -1.01 | 2.86 | ||||
AWH | 35.5M | 9.2M | -1.95 | 3.86 | ||||
APDN | 7.3M | 9.0M | -1.01 | 0.81 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
FONAR Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | -1.7% | 25.00 | 26.00 | 26.00 | 25.00 | 24.00 | 23.00 | 25.00 | 25.00 | 24.00 | 24.00 | 25.00 | 23.00 | 21.00 | 21.00 | 21.00 | 22.00 | 21.00 | 22.00 | 22.00 | 23.00 | 21.00 |
Costs and Expenses | 6.4% | 21.00 | 19.00 | 23.00 | 21.00 | 20.00 | 19.00 | 21.00 | 19.00 | 18.00 | 18.00 | 21.00 | 19.00 | 16.00 | 17.00 | 20.00 | 19.00 | 16.00 | 16.00 | 18.00 | 16.00 | 15.00 |
S&GA Expenses | 14.8% | 6.00 | 5.00 | 9.00 | 7.00 | 7.00 | 6.00 | 8.00 | 6.00 | 5.00 | 5.00 | 8.00 | 6.00 | 5.00 | 6.00 | 11.00 | 7.00 | 4.00 | 4.00 | 7.00 | 5.00 | 4.00 |
R&D Expenses | -10.9% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 1.00 |
EBITDA Margin | 6.5% | 0.24* | 0.22* | 0.20* | 0.21* | 0.23* | 0.25* | 0.27* | 0.28* | 0.27* | 0.26* | 0.24* | 0.21* | 0.19* | 0.19* | 0.21* | 0.24* | 0.29* | 0.30* | 0.30* | 0.31* | 0.29* |
Interest Expenses | -79.2% | 0.00 | 0.00 | - | - | 0.00 | 0.00 | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
Income Taxes | -18.2% | 1.00 | 2.00 | 1.00 | 0.00 | 1.00 | 1.00 | 0.00 | 2.00 | 1.00 | 1.00 | 2.00 | 0.00 | 1.00 | 1.00 | -0.40 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | -1.21 |
Earnings Before Taxes | -14.9% | 6.00 | 7.00 | 3.00 | 5.00 | 4.00 | 4.00 | 4.00 | 6.00 | 7.00 | 7.00 | 4.00 | 4.00 | 5.00 | 4.00 | 1.00 | 3.00 | 5.00 | 6.00 | 4.00 | 7.00 | 6.00 |
EBT Margin | 7.9% | 0.20* | 0.18* | 0.16* | 0.17* | 0.19* | 0.21* | 0.23* | 0.24* | 0.23* | 0.22* | 0.20* | 0.16* | 0.15* | 0.15* | 0.17* | 0.20* | 0.24* | 0.26* | 0.26* | 0.27* | 0.25* |
Net Income | -8.5% | 4.00 | 4.00 | 1.00 | 4.00 | 2.00 | 2.00 | 2.00 | 2.00 | 4.00 | 4.00 | 1.00 | 4.00 | 3.00 | 3.00 | 1.00 | 1.00 | 3.00 | 3.00 | 5.00 | 4.00 | 4.00 |
Net Income Margin | 12.1% | 0.13* | 0.11* | 0.10* | 0.11* | 0.09* | 0.11* | 0.13* | 0.11* | 0.13* | 0.13* | 0.11* | 0.12* | 0.09* | 0.09* | 0.10* | 0.14* | 0.17* | 0.17* | 0.18* | 0.24* | 0.24* |
Free Cashflow | 54.3% | 4.00 | 3.00 | 4.00 | 2.00 | 3.00 | 2.00 | 4.00 | 3.00 | 4.00 | 0.00 | 5.00 | 3.00 | 4.00 | 3.00 | 6.00 | 2.00 | 4.00 | 2.00 | 6.00 | -1.82 | 8.00 |
Balance Sheet | |||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q2 |
Assets | 0.4% | 202 | 202 | 201 | 199 | 197 | 198 | 199 | 196 | 194 | 188 | 190 | 187 | 185 | 183 | 180 | 134 |
Current Assets | 2.6% | 133 | 129 | 126 | 122 | 121 | 119 | 119 | 114 | 112 | 109 | 109 | 104 | 102 | 99.00 | 96.00 | 85.00 |
Cash Equivalents | 3.0% | 53.00 | 52.00 | 51.00 | 50.00 | 50.00 | 49.00 | 49.00 | 46.00 | 45.00 | 43.00 | 44.00 | 41.00 | 41.00 | 39.00 | 37.00 | 14.00 |
Net PPE | -4.7% | 20.00 | 21.00 | 22.00 | 23.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 21.00 | 21.00 | 17.00 |
Goodwill | 0% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 0.00 | 4.00 | 4.00 | 4.00 | 4.00 |
Liabilities | -3.2% | 46.00 | 47.00 | 50.00 | 49.00 | 49.00 | 51.00 | 53.00 | 51.00 | 51.00 | 49.00 | 54.00 | 50.00 | 50.00 | 53.00 | 54.00 | 15.00 |
Current Liabilities | -0.4% | 14.00 | 14.00 | 16.00 | 14.00 | 14.00 | 15.00 | 17.00 | 14.00 | 14.00 | 16.00 | 20.00 | 17.00 | 17.00 | 19.00 | 19.00 | 14.00 |
Long Term Debt | -11.5% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 |
LT Debt, Current | 0% | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -11.5% | 0.00 | 0.00 | 0.00 | 0.00 | - | - | 0.00 | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 6.4% | 164 | 154 | 158 | 157 | 148 | 147 | 146 | 148 | 142 | 139 | 135 | 135 | 132 | 128 | 126 | 118 |
Retained Earnings | 18.7% | -16.33 | -20.08 | -24.19 | -25.43 | -29.29 | -31.52 | -33.57 | -35.81 | -38.10 | -42.12 | -46.01 | -46.73 | -50.60 | -53.71 | -56.22 | -64.46 |
Additional Paid-In Capital | -1.1% | 181 | 183 | 183 | 184 | 184 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 183 | 183 | 181 |
Shares Outstanding | 0.6% | 6.00 | 6.00 | - | 6.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Minority Interest | -5.0% | -7.59 | -7.23 | -7.08 | -6.56 | -6.02 | -5.08 | -4.05 | -3.77 | -3.31 | -2.83 | -3.05 | -2.90 | -1.95 | -0.64 | 0.00 | 2.00 |
Float | - | - | - | - | - | 106 | - | - | - | 95.00 | - | - | - | 110 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 55.5% | 4,071 | 2,618 | 4,318 | 4,287 | 3,165 | 2,697 | 5,184 | 4,322 | 4,554 | 1,241 | 5,948 | 3,588 | 5,770 | 3,782 | 6,471 | 3,745 | 5,944 | 4,243 | 6,316 | 3,491 | 5,872 |
Cashflow From Investing | -68.4% | -133 | -79.00 | -698 | -2,204 | -473 | -963 | -766 | -1,723 | -1,481 | -1,209 | -646 | -1,940 | -1,798 | -435 | -960 | 13,300 | -2,349 | -2,568 | -421 | -15,874 | -1,814 |
Cashflow From Financing | -13.2% | -2,406 | -2,126 | -1,980 | -1,948 | -1,883 | -1,761 | -1,705 | -1,440 | -1,627 | -1,087 | -1,650 | -1,418 | -2,156 | -1,386 | 273 | -1,419 | -1,996 | -1,763 | -1,792 | -1,124 | -1,958 |
Buy Backs | 64.0% | 1,171 | 714 | 510 | 771 | 356 | 122 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
REVENUES | ||||
Patient fee revenue – net of contractual allowances and discounts | $ 8,221 | $ 7,129 | $ 16,896 | $ 13,205 |
Product sales – net | 55 | 170 | 219 | 200 |
Service and repair fees – net | 1,778 | 1,838 | 3,643 | 3,658 |
Service and repair fees - related parties – net | 28 | 28 | 55 | 55 |
Management and other fees – net | 12,316 | 12,092 | 24,436 | 24,342 |
Management and other fees - related medical practices – net | 2,988 | 2,999 | 5,975 | 5,987 |
Total Revenues – Net | 25,386 | 24,256 | 51,224 | 47,447 |
COSTS AND EXPENSES | ||||
Costs related to patient fee revenue | 4,602 | 4,023 | 9,029 | 7,822 |
Costs related to product sales | 302 | 214 | 405 | 383 |
Costs related to service and repair fees | 784 | 722 | 1,633 | 1,440 |
Costs related to service and repair fees - related parties | 12 | 11 | 25 | 22 |
Costs related to management and other fees | 7,208 | 6,622 | 14,231 | 13,124 |
Costs related to management and other fees – related medical practices | 1,590 | 1,492 | 3,109 | 2,890 |
Research and development | 416 | 342 | 883 | 691 |
Selling, general and administrative | 5,587 | 6,598 | 10,453 | 12,932 |
Total Costs and Expenses | 20,501 | 20,024 | 39,768 | 39,304 |
Income From Operations | 4,885 | 4,232 | 11,456 | 8,143 |
Other Income (Expense) | (208) | 1 | (197) | |
Other Income – Related party | 577 | 577 | ||
Interest Expense | (10) | (12) | (58) | (27) |
Investment Income | 534 | 263 | 1,040 | 414 |
Income Before Provision for Income Taxes and Non controlling Interests | 5,986 | 4,275 | 13,016 | 8,333 |
Provision for Income Taxes | (1,366) | (1,463) | (3,036) | (2,871) |
Net Income | 4,620 | 2,812 | 9,980 | 5,462 |
Net Income – Non controlling Interests | (861) | (580) | (2,115) | (1,183) |
Net Income – Attributable to FONAR | $ 3,759 | $ 2,232 | $ 7,865 | $ 4,279 |
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands | Dec. 31, 2023 | Jun. 30, 2023 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 53,225 | $ 51,280 |
Short-term investments | 33 | 33 |
Accounts receivable – net | 3,881 | 3,861 |
Accounts receivable - related party | 60 | |
Medical receivable – net | 22,548 | 21,259 |
Management and other fees receivable – net | 39,352 | 35,888 |
Management and other fees receivable – related medical practices – net | 9,267 | 9,162 |
Inventories | 2,835 | 2,570 |
Prepaid expenses and other current assets | 1,341 | 1,608 |
Total Current Assets | 132,542 | 125,661 |
Accounts receivable – long term | 376 | 710 |
Note receivable – related party | 577 | |
Deferred income tax asset | 7,758 | 10,042 |
Property and equipment – net | 20,109 | 22,146 |
Right-of-use Asset – operating lease | 32,234 | 33,069 |
Right-of-use Asset – financing lease | 630 | 729 |
Goodwill | 4,269 | 4,269 |
Other intangible assets – net | 3,266 | 3,432 |
Other assets | 501 | 524 |
Total Assets | 202,262 | 200,582 |
Current Liabilities: | ||
Current portion of long-term debt | 45 | 44 |
Accounts payable | 1,335 | 1,579 |
Other current liabilities | 3,460 | 5,444 |
Unearned revenue on service contracts | 3,804 | 3,832 |
Unearned revenue on service contracts – related party | 55 | |
Operating lease liability - current portion | 4,658 | 3,905 |
Financing lease liability - current portion | 222 | 218 |
Customer deposits | 600 | 602 |
Total Current Liabilities | 14,179 | 15,624 |
Long-Term Liabilities: | ||
Unearned revenue on service contracts | 376 | 760 |
Deferred income tax liability | 395 | 395 |
Due to related medical practices | 93 | 93 |
Operating lease liability – net of current portion | 30,299 | 32,105 |
Financing lease liability – net of current portion | 508 | 620 |
Long-term debt, less current portion | 92 | 115 |
Other liabilities | 23 | 42 |
Total Long-Term Liabilities | 31,786 | 34,130 |
Total Liabilities | 45,965 | 49,754 |
Paid-in capital in excess of par value | 180,607 | 182,613 |
Accumulated deficit | (16,326) | (24,191) |
Treasury stock, at cost - 4 shares of common stock at December 31, 2023 and 11 shares of common stock at June 30, 2023 | (395) | (516) |
Total Fonar Corporation’s Stockholders’ Equity | 163,887 | 157,907 |
Non controlling interests | (7,590) | (7,079) |
Total Stockholders’ Equity | 156,297 | 150,828 |
Total Liabilities and Stockholders’ Equity | 202,262 | 200,582 |
Class A Non Voting Preferred Stock [Member] | ||
Long-Term Liabilities: | ||
Preferred stock value | ||
Preferred Stock [Member] | ||
Long-Term Liabilities: | ||
Preferred stock value | ||
Common Stock [Member] | ||
Long-Term Liabilities: | ||
Common stock value | 1 | 1 |
Common Class B [Member] | ||
Long-Term Liabilities: | ||
Common stock value | ||
Common Class C [Member] | ||
Long-Term Liabilities: | ||
Common stock value |